• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中呼吸链复合体I亚基的缺陷。

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

作者信息

Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y

机构信息

Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

Biochem Biophys Res Commun. 1989 Sep 29;163(3):1450-5. doi: 10.1016/0006-291x(89)91141-8.

DOI:10.1016/0006-291x(89)91141-8
PMID:2551290
Abstract

Immunoblotting studies on mitochondria prepared from the striata of patients who died of Parkinson's disease were performed using specific antisera against Complexes I, III and IV. In 4 out of 5 patients with Parkinson's disease, the 30-, 25- and 24-kDa subunits of Complex I were moderately to markedly decreased. No clear difference was noted in immunoblotting studies on subunits of Complexes III and IV between the control and Parkinson's disease. Deficiencies in Complex I subunits seem to be one of the most important clues to elucidate pathogenesis of Parkinson's disease.

摘要

使用针对复合物I、III和IV的特异性抗血清,对死于帕金森病患者的纹状体中制备的线粒体进行免疫印迹研究。在5例帕金森病患者中,有4例复合物I的30 kDa、25 kDa和24 kDa亚基中度至明显减少。在对照组和帕金森病组之间,复合物III和IV亚基的免疫印迹研究未发现明显差异。复合物I亚基的缺陷似乎是阐明帕金森病发病机制的最重要线索之一。

相似文献

1
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.帕金森病中呼吸链复合体I亚基的缺陷。
Biochem Biophys Res Commun. 1989 Sep 29;163(3):1450-5. doi: 10.1016/0006-291x(89)91141-8.
2
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.帕金森病中线粒体复合物I、II、III和IV的免疫组织化学研究。
Ann Neurol. 1991 Oct;30(4):563-71. doi: 10.1002/ana.410300409.
3
Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes.帕金森病患者血小板的电子传递复合物I和IV异常,但帕金森叠加综合征患者的则正常。
Brain. 1993 Dec;116 ( Pt 6):1451-63. doi: 10.1093/brain/116.6.1451.
4
Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Grupo-Centro de Trastornos del Movimiento.未经治疗的帕金森病患者淋巴细胞分离线粒体中的呼吸链酶活性。运动障碍研究小组 - 中心
Neurology. 1996 May;46(5):1343-6. doi: 10.1212/wnl.46.5.1343.
5
Partial deficiency of subunits in complex I or IV of patients with mitochondrial myopathies.线粒体肌病患者复合体I或复合体IV中亚基的部分缺陷。
Biochem Int. 1987 Mar;14(3):525-30.
6
Mitochondrial complex I deficiency in Parkinson's disease.帕金森病中的线粒体复合体I缺乏症。
J Neurochem. 1990 Mar;54(3):823-7. doi: 10.1111/j.1471-4159.1990.tb02325.x.
7
Abnormalities of the electron transport chain in idiopathic Parkinson's disease.特发性帕金森病中电子传递链的异常
Ann Neurol. 1989 Dec;26(6):719-23. doi: 10.1002/ana.410260606.
8
A novel mutation selectively decreases complex I and cytochrome c oxidase subunits in Chinese hamster mitochondria.一种新的突变选择性地降低了中国仓鼠线粒体中复合体I和细胞色素c氧化酶亚基的含量。
J Biol Chem. 1984 Sep 10;259(17):11103-13.
9
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.辅酶Q10水平与帕金森病患者和非帕金森病患者线粒体中复合物I及复合物II/III的活性相关。
Ann Neurol. 1997 Aug;42(2):261-4. doi: 10.1002/ana.410420221.
10
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
J Neurochem. 1990 Dec;55(6):2142-5. doi: 10.1111/j.1471-4159.1990.tb05809.x.

引用本文的文献

1
Role of Cellular Senescence in Parkinson's Disease: Potential for Disease-Modification Through Senotherapy.细胞衰老在帕金森病中的作用:通过衰老疗法进行疾病修饰的潜力。
Biomedicines. 2025 Jun 7;13(6):1400. doi: 10.3390/biomedicines13061400.
2
Modulation of Autophagy and Nitric Oxide Signaling via Glycyrrhizic Acid and 7-Nitroindazole in MPTP-induced Parkinson's Disease Model.在MPTP诱导的帕金森病模型中通过甘草酸和7-硝基吲唑对自噬和一氧化氮信号通路的调节
Ann Neurosci. 2024 Oct;31(4):265-276. doi: 10.1177/09727531231191661. Epub 2023 Aug 27.
3
Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease.
抗糖尿病药物二甲双胍在治疗人类疾病中的多种应用。
Pharmaceuticals (Basel). 2024 Nov 27;17(12):1601. doi: 10.3390/ph17121601.
4
Metabolic Dysfunction in Parkinson's Disease: Unraveling the Glucose-Lipid Connection.帕金森病中的代谢功能障碍:揭示葡萄糖 - 脂质关联
Biomedicines. 2024 Dec 13;12(12):2841. doi: 10.3390/biomedicines12122841.
5
Mitochondrial dysfunction in Parkinson's disease.帕金森病中的线粒体功能障碍。
J Neural Transm (Vienna). 2024 Dec;131(12):1415-1428. doi: 10.1007/s00702-024-02863-2. Epub 2024 Nov 25.
6
Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson's and other related neurodegenerative diseases.氧化应激诱导的神经退行性变中的核孔和核质转运障碍:与帕金森病等相关神经退行性疾病发病机制中的分子机制的相关性。
Mol Neurodegener. 2024 Nov 23;19(1):87. doi: 10.1186/s13024-024-00774-0.
7
Ketone ester-enriched diet ameliorates motor and dopamine release deficits in MitoPark mice.富含酮酯的饮食改善了MitoPark小鼠的运动和多巴胺释放缺陷。
Eur J Neurosci. 2024 Dec;60(11):6875-6890. doi: 10.1111/ejn.16601. Epub 2024 Nov 11.
8
Heterozygous loss of Engrailed-1 and α-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence.Engrailed-1 杂合缺失和 α-突触核蛋白病 (En1/SYN):帕金森病的双重打击临床前小鼠模型,采用人工智能进行分析。
Neurobiol Dis. 2024 Oct 1;200:106647. doi: 10.1016/j.nbd.2024.106647. Epub 2024 Aug 24.
9
Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction.颠覆帕金森病认知的革命:海因茨·赖希曼博士的开拓性研究与未来研究方向。
J Neural Transm (Vienna). 2024 Dec;131(12):1367-1387. doi: 10.1007/s00702-024-02812-z. Epub 2024 Aug 7.
10
Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?重新思考帕金森病:多巴胺减少疗法是否具有临床应用价值?
J Neurol. 2024 Aug;271(8):5687-5695. doi: 10.1007/s00415-024-12526-7. Epub 2024 Jun 21.